NICE guidance (TA875) specifies that semaglutide for weight management should only be prescribed as part of a specialist weight management service, which typically includes access to dietitians, psychologists, and specialist physicians or nurses
10.1186/s12933-018-0682-3 62
doi: 10.1016/j.jacc.2013.11.004 24 GarveyWTMechanickJIBrettEMGarberAJHurleyDLJastreboffAMet al
Psychiatric adverse events associated with GLP-1 receptor agonists: a real-world pharmacovigilance study based on the FDA adverse event reporting system database
A quick check before you draw your dose catches most of the errors that cause dosing confusion in the first place
Common side effects include nausea, vomiting, diarrhea, and constipation, typically mild and transient during dose escalation